KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Thermo Fisher Scientific (TMO) Shares Outstanding (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Shares Outstanding readings, the most recent being $445.0 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding changed 0.23% to $445.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $445.0 million, a 0.23% change, with the full-year FY2025 number at $445.2 million, changed 0.3% from a year prior.
  • Shares Outstanding hit $445.5 million in Q1 2026 for Thermo Fisher Scientific, roughly flat from $445.2 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $445.5 million in Q1 2026 to a low of $439.9 million in Q3 2022.
  • Median Shares Outstanding over the past 5 years was $443.0 million (2024), compared with a mean of $442.7 million.
  • Biggest five-year swings in Shares Outstanding: soared 877.78% in 2022 and later increased 0.23% in 2026.
  • Thermo Fisher Scientific's Shares Outstanding stood at $441.0 million in 2022, then increased by 0.23% to $442.0 million in 2023, then rose by 0.45% to $444.0 million in 2024, then increased by 0.26% to $445.2 million in 2025, then dropped by 0.04% to $445.0 million in 2026.
  • The last three reported values for Shares Outstanding were $445.0 million (Q1 2026), $445.2 million (Q4 2025), and $445.0 million (Q3 2025) per Business Quant data.